The report titled “Fluoroscopy Market: Global Demand Analysis & Opportunity Outlook 2027”delivers the detailed overview of the global fluoroscopy market in terms of market segmentation by surgery, by end-use and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The global fluoroscopy market can be segmented on the basis of surgery, end-use and region. On the basis of surgery, it is sub-segmented into biopsy, cardiovascular interventions, orthopedic surgeries and others. The cardiovascular interventions are expected to be the leading sub-segment for the surgery segment during the forecast period.
The increasing cases of the cardiovascular diseases is anticipated to increase the demand for the cardiovascular interventions surgery which in turn is anticipated to boost the growth of the cardiovascular interventions surgery segment during the forecast period. On the basis of end-use, it is sub-segmented into diagnostic centers, hospitals and clinics. Hospitals is anticipated to be the largest sub-segment during the forecast period. The availability of high quality healthcare devices coupled with increasing number of patients is anticipated to boost the growth of the sub-segment during the forecast period.
Get Exclusive Sample Report Copy Of This Report @ https://www.researchnester.com/sample-request-738
The global fluoroscopy market is anticipated to expand at a significant CAGR during 2018-2027. The increasing demand for the minimally invasive technique coupled with the rising occurrence of the chronic diseases is anticipated boost the growth of the fluoroscopy market globally.
By region, global fluoroscopy market is segmented into North America, Asia-Pacific, Latin America, Europe, Middle East and Africa. North America is anticipated to lead the global fluoroscopy market during the forecast period. The presence of the highly developed healthcare infrastructure in the region coupled with stringent government rules regarding the surgeries is anticipated to be the major factor for the region to lead the global fluoroscopy market during the forecast period.
Asia-Pacific region is anticipated to be the fastest growing region for the global fluoroscopy market. The favorable healthcare policies are also anticipated to be major factor for the growth of the Global Fluoroscopy Market. The growing aged population in region is increasing the demand for the enhanced diagnosis which in turn is anticipated to propel the market growth of the fluoroscopy.
In Q4 2021, USA current-account deficit widened stood at $224.8 billion. However, in Q1 22, CAD rose by 29.6%, reached to $291.4 billion, adding $66.6 billion to the gap. Export of good and services increased by $25.7 billion to reach $1.03 trillion in the first quarter of 2022. However, goods and services deficit was $79.6 billion in June, down $5.3 billion from $84.9 billion in May, revised- reflecting some sight of relief. On the other hand, annual inflation rate in the country hit 8.5%. Energy CPI surged by 32.9% in July 2022, inflating the cost of logistic and some signs to disrupt supply chain whilst electricity cost upsurged by 15.2%, highest since Feb 2006. Apart from that, In July 2022, existing US home sales declined 5.9% to 4.81 million (seasonally adjusted annual rate), the lowest since May of 2020 and below market expectations of 4.89 million. As mortgage rate touches to peak 6%, sales for houses declined for a sixth consecutive month. Global energy crises to remain at focal point, pushing consumers to spend less on the products and services and save more.
On the other hand, the worst is expected to be seen in the European countries especially during 2022 winters. The energy and gas crises has already started grappling the region where in many Western European countries including Germany is looking for coal fired solutions to tackle the gas supply shortage, created by Russian-Ukraine conflict.
Amidst global concerns, market players have started looking for safe investments by holding on to the new technology and product launches. Factors like currency translation, disruption in global supply chain, Anti-China sentiments brewing across the globe, slowdown in Chinese economy, inflated products prices, USD getting stronger every week, decreasing purchasing power and strict measures taken by central banks/institutions across the world to ensure less spending and more saving, could hit the demand for the product and service badly in near future.
Healthcare Companies and Private Service Providers to have a minimal damage Caused by Inflation:
As US govt. remains committed to quality by spending more in the Medicaid and Medicare programs, incentives by govt. to medical devices, pharma companies and biotech to benefit the market players in short and long term goals. In 2021, U.S. spent $12,318/person on healthcare- highest amongst all OECD countries followed by Germany at $7,383. The federal government commitment towards healthcare systems to enable market players expanding their revenues and mitigating the risk posed by the inflation.
Increasing demand for the minimally invasive technique for the treatment of disease is anticipated to boost the demand for the fluoroscopy
The fluoroscopy presents the real time image for the diagnostic purpose. The soft and hard tissue can be easily diagnosed with the help of the fluoroscopy as it is a vital tool for the medical purpose. The medical imaging of patient consists of various processes such as diagnosis and therapy delivery. The primary role of the imaging is in diagnostics. Thus, rising prevalence of the minimally invasive technique in the diagnosis of the diseases is anticipated to be the major factor for the growth of the fluoroscopy. The minimally invasive techniques provide the exact information about the prevailing disease. Thus chronic diseases can be easily diagnosed with the help of a minimally invasive technique.
This report also provides the existing competitive scenario of some of the key players of the global fluoroscopy market which includes company profiling of key companies such as GE Healthcare, Toshiba Medical Systems Corporation, Orthoscan Inc., Canon U.S.A. Inc., Shimadzu Corporation, Hologic Inc., Carestream Health, Siemens Medical Solutions, Philips N.V., Hitachi Ltd., Amico X-ray technologies and Ziehm Imaging GmbH.
The outlining enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global fluoroscopy market that is expected to help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Get Exclusive Sample Report Copy Of This Report @ https://www.researchnester.com/sample-request-738
About Us
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact Us
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 591